In a new case study, researchers from North Carolina State University found that a family suffering from illnesses that ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Treatment with IV edaravone for ALS was linked to a slowing of disease-progression milestones compared with no IV edaravone ...

The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...

As cases of GBS surge past 100 in Pune, the Neurological Society of Pune has urged people not to panic and reassured them ...

A fatal neurological disease is hitting NEPA wildlife. Two separate cases of Chronic Wasting Disease (CWD) have been ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...

A cancer diagnosis can feel overwhelming, bringing fear, uncertainty, and emotional turmoil for one and all. Read on.

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...

By identifying biomarkers of brain disorders, Cove Neurosciences is working to speed up the development of new treatments.

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s diseaseONAPGO is a wearable subcutaneous infusion ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...